ALGEN logo

genOway Société anonyme Stock Price

ENXTPA:ALGEN Community·€23.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

ALGEN Share Price Performance

€2.50
-1.35 (-35.06%)
€2.50
-1.35 (-35.06%)
Price €2.50

ALGEN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
1 Reward

genOway Société anonyme Key Details

€27.2m

Revenue

€12.4m

Cost of Revenue

€14.8m

Gross Profit

€13.5m

Other Expenses

€1.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.14
54.33%
4.74%
78.8%
View Full Analysis

About ALGEN

Founded
1999
Employees
148
CEO
Alexandre Fraichard
WebsiteView website
www.genoway.com

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France.

Recent ALGEN News & Updates

Recent updates

No updates